Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

New Antibody therapy to fight Cancer

  • Broadcast in Health
Powerful Patient

Powerful Patient


Follow This Show

If you liked this show, you should follow Powerful Patient.
Robert Brooke, CEO of Genesis Biopharma, talks with Joyce about their new antibody therapy, recently approved by the European Patent Office for use as a therapeutic treatment in multiple cancers. Genesis Biopharma is developing its anti-CD55 antibody therapy to neutralize a key cancer defense mechanism that has been found to be over-expressed in more than 80% of solid tumors. The therapy could provide a safe alternative to toxic chemotherapy regimens. The company is initially addressing metastatic colorectal cancer and lymphoma and will be setting up trials to determine its effectivness with other cancers as well.